Simin Farokhi

Simin Farokhi

Auto-generated profile, based on publicly available information

Simin Farokhi

USERN Office, Lorestan University of Medical Sciences, Khorramabad, Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2024 in Discover Applied Sciences
Verified
Journal Article
Open access
PDF file
SFSimin Farokhi
Simin Farokhi
ZRZahraSadat (Farnaz) Razavi
ZahraSadat (Farnaz) Razavi
MMMaryamosadat Mavaei
Maryamosadat Mavaei
ASAlireza Shadab
Alireza Shadab
HAHamed Afkhami
Hamed Afkhami
HSHadi Sardarabadi
Hadi Sardarabadi
Arteriosclerosis (AS) presents a significant global health challenge, demanding innovative therapeutic strategies. This review explores the potential of nanoparticles (NPs) and mesenchymal stem cells (MSCs) as promising modalities for treating AS. NPs enable targeted drug delivery, while MSCs possess immunomodulatory and regenerative capabilities. We discuss recent advances in NP-based drug delivery systems tailored for AS treatment and highlight MSCs’ roles in modulating inflammation and promoting vascular repair. Additionally, we examine the synergistic effects of combining NPs and MSCs for enhanced therapeutic outcomes. Furthermore, this paper provides insights into targeting endothelial cells, T-cells, macrophages, lipid levels, and plaques in AS using MSCs. It also reviews various types of metal-based and non-metallic NPs utilized in AS therapy. This comprehensive overview underscores the potential synergies between MSCs and NPs in cardiovascular disease therapy, emphasizing the need for further research to fully realize their therapeutic implications. Graphical Abstract

11 July 2025 in Immuno
Verified
Journal Article
Open access
PDF file
SFSimin Farokhi
Simin Farokhi
STSeyed Mehdi Tabaie
Seyed Mehdi Tabaie
AFArshia Fakouri
Arshia Fakouri
SMShirin Manshouri
Shirin Manshouri
NENikoo Emtiazi
Nikoo Emtiazi
FSFarhad Seif
Farhad Seif
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a multifaceted inflammatory disorder characterized by distinct immunopathogenic entities, including type 2 inflammation mediated by cytokines such as interleukin-4 (IL-4), IL-5, and IL-13. These cytokines contribute to eosinophilic inflammation, epithelial barrier dysfunction, and mucus overproduction, resulting in polyp formation. Advances in molecular understanding have resulted in the identification of CRSwNP endotypes, suggesting personalized treatment approaches. Conventional therapies, such as intranasal and systemic corticosteroids, provide symptom relief but are restricted by side effects and polyp recurrence, necessitating the development of novel targeted approaches. Biologic therapies represent a breakthrough in CRSwNP management. Monoclonal antibodies such as dupilumab, omalizumab, mepolizumab, and Benralizumab (IL-5 receptor alpha) target key mediators of type 2 inflammation, leading to substantial improvements in polyp size, symptom control, and quality of life. Additionally, emerging therapies like tezepelumab and brodalumab aim to address broader immune mechanisms, including type 1 and type 3 inflammation. These advancements enable tailored treatment approaches that optimize outcomes and reduce reliance on surgical interventions. Biomarker-driven research continues to refine CRSwNP classification and treatment efficacy, emphasizing precision medicine. Future efforts should focus on expanding the therapeutic landscape, investigating long-term impacts of biologics, and exploring their combinatory potential to improve disease control. This review discusses the role of innate and adaptive immunity in the pathogenesis of CRSwNP and suggests novel cytokine-targeted strategies for further considering personalized medicine in future therapeutic plans.

20 June 2025 in International Journal of Surgery
Verified
Journal Article
Open access
MMMahsa Motiei
Mahsa Motiei
SMSahand Sadat Mansouri
Sahand Sadat Mansouri
ATAmirhossein Tamimi
Amirhossein Tamimi
SFSimin Farokhi
Simin Farokhi
AFArshia Fakouri
Arshia Fakouri
AHAfagh Hassanzadeh-Rad
Afagh Hassanzadeh-Rad
Background: Breast cancer is the most prevalent malignancy in women and a leading cause of mortality. Accurate assessment of axillary lymph node metastasis (LNM) is critical for breast cancer management. Exploring non-invasive methods such as radiomics for the detection of LNM is highly important. Methods: We systematically searched PubMed, Embase, Scopus, Web of Science and google scholar until 11 March 2024. To assess the risk of bias and quality of studies, we utilized the quality assessment of diagnostic accuracy studies (QUADAS) tool as well as the radiomics quality score (RQS). Area under the curve (AUC), sensitivity, specificity and accuracy were determined for each study to evaluate the diagnostic accuracy of radiomics in magnetic resonance imaging (MRI) for detecting LNM in patients with breast cancer. Results: This meta-analysis of 20 studies (5072 patients) demonstrated an overall AUC of 0.83 (95% confidence interval (CI): 0.80–0.86). Subgroup analysis revealed a trend toward higher specificity when radiomics was combined with clinical factors (0.83) compared to radiomics alone (0.79). Sensitivity analysis confirmed the robustness of the findings and publication bias was not evident. The radiomics models increased the likelihood of a positive LNM outcome from 37% to 73.2% when initial probability was positive and decreased the likelihood to 8% when initial probability was negative, highlighting their potential clinical utility. Conclusion: Radiomics as a non-invasive method demonstrates strong potential for detecting LNM in breast cancer, offering clinical promise. However, further standardization and validation are needed in future studies.

1 January 2026 in International Journal of Breast Cancer
Verified
Journal Article
Open access
BABahar Amiri
Bahar Amiri
MAMahta Mellat Ardakani
Mahta Mellat Ardakani
APAli Pajouhi
Ali Pajouhi
AAAtieh Akbari
Atieh Akbari
SFSimin Farokhi
Simin Farokhi
MBMania Beiranvand
Mania Beiranvand
Background: Examining the survival rate in breast cancer patients serves as a metric for assessing and advancing various treatment modalities. In light of the significant incidence of breast cancer in Iran, this study is aimed at examining and comparing the disease‐free survival (DFS) and overall survival (OS) rates among breast cancer patients who underwent axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB). Patients and Methods: This retrospective cohort research included 1071 patients at Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran, from 1991 to 2021. The recurrence and survival rates of patients undergoing ALND and SLNB in both groups were examined and evaluated. The data were analyzed using SPSS statistical software using descriptive statistical techniques (percentage, frequency, mean, and standard deviation), Kaplan–Meier analysis, and Cox regression tests. A significance threshold of 0.05 is used. Results: The average OS among all patients was 18.08 ± 0.51. The average OS in the ALND group was 18.1 ± 0.53; in the SLNB group, it was 12.8 ± 0.39, which was insignificant ( p < 0.05). The average DFS among all patients was 17.13 ± 0.51. The average DFS in the ALND group was 16.95 ± 0.54; in the SLNB group, it was 11.96 ± 0.3; the difference was insignificant ( p = 0.11). Conclusion: OS and DFS in the ALND group were higher than in the SLNB group, but they were not statistically significant.

26 March 2023 in Iranian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
SAShokoufeh Ahmadipour
Shokoufeh Ahmadipour
GMGolnaz Mahmoudvand
Golnaz Mahmoudvand
AFArshia Fakouri
Arshia Fakouri
SFSimin Farokhi
Simin Farokhi
Arian Karimi RouzbahaniArian Karimi Rouzbahani
Arian Karimi Rouzbahani
Introduction: Sodium leak channel, non-selective (NALCN) is an ion channel with an important function in neuronal excitability. The activity of NALCN is essential in the balance of rhythmic behaviors. Infantile hypotonia with psychomotor retardation and characteristic facies 1 (IHPRF1), which occurs due to biallelic NALCN variants, leads to dysmorphic characteristics and global developmental delay. We hereby report 2 non-related patients with IHPRF1 syndrome. Case Presentation: The first case was a 1 - year-old girl referred to our center because of constipation and poor weight gain, and the other was a 2 - year-old girl presenting with hypotonia, constipation, and poor weight gain. Whole exome sequencing led to the detection of homozygote NALCN variants. Interestingly, in both cases, a novel variant of c.1434 + 1G>A in NACLN was identified, which, to the best of our knowledge, has not been reported as a pathogenic variant so far. Conclusions: NALCN dysfunctions lead to rare yet clinically significant disorders. Due to the potential mortality, further studies are essential for a more comprehensive understanding of these rare disorders.

13 May 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
MJMohammad Joudaki
Mohammad Joudaki
PKParya Khani
Parya Khani
SFSimin Farokhi
Simin Farokhi
SSShahram Msc Ahmadi Somaghian
Shahram Msc Ahmadi Somaghian
SRSarah Rahimi
Sarah Rahimi
APAli Pajouhi
Ali Pajouhi
Background: Breast cancer is one of the most common causes of cancer death in women both globally and in Iran. Although medical breakthroughs have improved its prognosis, different characteristics can vary locally, especially in understudied regions. Therefore, the present study was designed and carried out in 2022 to compare the rate of breast cancer recurrence in Luminal A and triple-negative patients referred to the Shahid Rahimi Hospital in Khorramabad from March 2019 to March 2020. Materials and methods: This study was a descriptive-analytical cross-sectional study designed and conducted on 59 patients diagnosed with Luminal A and triple-negative breast cancer treated at the Shahid Rahimi Hospital from March 2019 to March 2020. In this study, the data collection instrument was a researcher-designed form that included information such as age, history of recurrence, type of cancer, family history of cancer, personal history of cancer, lymph node involvement, hookah use history, smoking history, breastfeeding history, and material status. Finally, after collecting information, data was analyzed using SPSS software version 25. Results: The average age of the patients in this study was 49.45 ± 6.01 years, and the youngest and oldest patients were 35 and 62 years, respectively. Among the studied patients, 34 individuals (57.63%) had Luminal A cancer, and 25 patients (42.37%) had triple negative cancer. Recurrence was reported in 23 patients (38.98%), and lymph node involvement was reported in 21 patients (35.59%). Moreover, 14 patients (23.73%) were positive for a personal history of cancer, and 22 patients (37.29%) had a family history of cancer. In this study, the relationship between recurrence and type of cancer and involvement of lymph nodes was statistically significant ( P < 0.05). Conclusion: The rate of recurrence in patients with Luminal A cancer was higher than in patients with triple-negative cancer, according to the results of the study. More attention and periodic examinations in terms of recurrence in patients with Luminal A cancer were necessary.